Quinto Gesiotto, MD, discusses optimal dosing strategies for ponatinib in the treatment of chronic-phase chronic myeloid leukemia.
Quinto Gesiotto, MD
Advertisement
Quinto Gesiotto, MD, is a malignant hematologist at Tampa General Hospital in Florida.
Articles by Quinto Gesiotto, MD
Quinto Gesiotto, MD, discusses optimal ponatinib dosing strategies and evolving TKI sequencing considerations in chronic myeloid leukemia.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Ensartinib Reduces Recurrence Risk After Resection in ALK-Positive NSCLC
2
FDA Approves Pembrolizumab Plus Enfortumab Vedotin in MIBC
3
FDA Approves Subcutaneous Isatuximab Delivered Via On-Body Delivery System for Multiple Myeloma
4
Rocbrutinib Displays Durable Activity in Covalent BTK Inhibitor–Pretreated R/R MCL
5